Entera Bio (ENTX) Earnings Date & Reports

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ENTX is expected to report earnings to rise 83.33% to -10 cents per share on August 08

Q2'25

Est.

$-0.11

Q1'25

Beat

by $0.01

Q4'24

Est.

$-0.06

Q3'24

Missed

by $0.03

Q2'24

Est.

$-0.06

The last earnings report on May 09 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 8.41K shares outstanding, the current market capitalization sits at 97.65M.

View a ticker or compare two or three

Compare

ENTX